Research programme: interleukin 10 variants - GenOdyssee

Drug Profile

Research programme: interleukin 10 variants - GenOdyssee

Alternative Names: GOIL-10s; IL-10 - GenOdyssee; interleukin 10 - GenOdyssee

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator GenOdyssee
  • Class Anti-inflammatories; Interleukins
  • Mechanism of Action Interleukin-10 replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Autoimmune disorders

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Autoimmune-disorders in France
  • 07 Apr 2006 Preclinical trials in Autoimmune disorders in France (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top